Synthetic DNA

Genome editing concept
#Bacteriophage #Genome editing #Synthetic DNA

New method shows ‘sky’s the limit’ for genome editing 

Scientists have developed a new method to construct bacteriophages with entirely synthetic genetic material, allowing them to edit genomes gene by gene.  Researchers at the University of Pittsburgh, US, led by Graham Hatfull, developed the method to add and subtract genes from the synthetic genome at will. Read More

#News

#Biomanufacturing #Collaboration #Genetics / genomics #Synthetic biology #Synthetic DNA

Synthetic biology collaboration to develop plant genomics

A collaborative project led by the Max-Planck Institute of Molecular Plant Physiology (MPI-MP), Germany, aims to develop synthetic chloroplast genomes.  Enzymatic DNA synthesis company Camena Bioscience and whole genome writing specialists Constructive Bio are the latest companies to join the project.  Until now, constructing synthetic… Read More

#News

#Drug discovery #Genetics / genomics #Synthetic biology #Synthetic DNA

Enzymatic DNA synthesis: Moving beyond limits

Dr Thomas Ybert, Co-founder and Chief Scientific Officer at DNA Script, describes how recent advancements in enzymatic DNA synthesis are unlocking previously inaccessible regions of the genome. Synthetic nucleic acids are foundational tools in biological research and therapeutic development, essential for applications ranging from gene synthesis to mRNA vaccine templates. Read More

#Exclusive Content

#bit bio #CAR-T #CRISPR #Drug development #Drug discovery #Stem cells #Synthetic biology #Synthetic DNA

New podcast: An overview on the impact of synthetic biology

This is the latest episode of the free DDW narrated podcast, titled “An overview on the impact of synthetic biology”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “Synthetic biology: Impacting drug discovery” and “Synthetic biology: Innovating in drug… Read More

#News

#Biotherapeutics #DNA #Drug discovery #Gut microbiome #Microbiome #Precision medicine #Synthetic biology #Synthetic DNA

Podcast: How is precision medicine making its mark in drug discovery?

This is the latest episode of the free DDW narrated podcast, titled “How is precision medicine making its mark in drug discovery?”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “Accelerating biotherapy and personalised medicine with long DNA”… Read More

#News

#Gene synthesis #Genetic medicines #Guide #Synthetic DNA

Guide: Next generation cell-free gene synthesis

Struggling to make sense of the strategies, technology and trade-offs when developing a DNA supply chain? Elegen has created a comprehensive overview of the evolving field of gene synthesis entitled ‘The Next-Gen DNA Buyers Guide: From design to results faster and more reliably with cell-free gene synthesis’. The Guide… Read More

#News

#Gene synthesis #Genetic medicines #Synthetic DNA

Next generation cell-free gene synthesis

Struggling to make sense of the strategies, technology and trade-offs when developing a DNA supply chain? Elegen created a comprehensive overview of the evolving field of gene synthesis. This Guide contains a detailed comparison of 10 industry-leading vendors, including key metrics such as error rate, turnaround time, cost, and maximum… Read More

#Intelligence #Resources

#Drug discovery #Protein chemistry / Proteomics #Protein engineering #Synthetic biology #Synthetic DNA #Webinar

Webinar: Synthetic DNA for protein screening in a cell-free system

A new webinar is now open for registration entitled ‘Using ENFINIA cell-free synthesised DNA for rapid protein expression and screening in the myTXTL cell-free system‘. Cell-free transcription-translation (TXTL) systems can be used for rapid and flexible protein expression and screening workflows, powering protein engineering and discovery, synthetic biology, AI-driven… Read More

Webinar date:
Supported by Elegen Bio
#News

#Drug discovery #Protein chemistry / Proteomics #Protein engineering #Synthetic biology #Synthetic DNA #Webinar

Register now: Synthesised DNA for protein screening

A new webinar is now open for registration entitled ‘Using ENFINIA cell-free synthesised DNA for rapid protein expression and screening in the myTXTL cell-free system‘. Cell-free transcription-translation (TXTL) systems can be used for rapid and flexible protein expression and screening workflows, powering protein engineering and discovery, synthetic biology, AI-driven… Read More

Webinar date:
Supported by Elegen Bio
#News

Synthetic DNA
#Drug discovery #Protein chemistry / Proteomics #Protein engineering #Synthetic biology #Synthetic DNA #Webinar

Webinar: Successfully express high-quality synthetic DNA in TXTL systems

A new webinar is now open for registration entitled ‘Using ENFINIA cell-free synthesised DNA for rapid protein expression and screening in the myTXTL cell-free system‘. Cell-free transcription-translation (TXTL) systems can be used for rapid and flexible protein expression and screening workflows, powering protein engineering and discovery, synthetic biology, AI-driven… Read More

Webinar date:
Supported by Elegen Bio
#News

Synthetic DNA
#Drug discovery #Protein chemistry / Proteomics #Protein engineering #Synthetic biology #Synthetic DNA #Webinar

Webinar: Ensure rapid, efficient and streamlined in vitro workflows

A new webinar is now open for registration entitled ‘Using ENFINIA cell-free synthesised DNA for rapid protein expression and screening in the myTXTL cell-free system‘. Cell-free transcription-translation (TXTL) systems can be used for rapid and flexible protein expression and screening workflows, powering protein engineering and discovery, synthetic biology, AI-driven… Read More

Webinar date:
Supported by Elegen Bio
#News

Synthetic DNA
#Drug discovery #Protein chemistry / Proteomics #Protein engineering #Synthetic biology #Synthetic DNA

Using ENFINIA™ cell-free synthesised DNA for rapid protein expression and screening in the myTXTL® cell-free system

Cell-free transcription-translation (TXTL) systems can be used for rapid and flexible protein expression and screening workflows, powering protein engineering and discovery, synthetic biology, AI-driven approaches, biomanufacturing, and more. However, reliance on plasmid DNA templates for expression requires time-consuming cloning steps, limiting speed and efficiency. In this webinar, supported by Elegen,… Read More

Webinar date:
Supported by Elegen
#Webinars

Synthetic DNA molecule
#Genetic editing #Genetics / genomics #Synthetic biology #Synthetic DNA #University of Southern California

Novel technique opens up new possibilities in synthetic genomics

A new technique to clone and reassemble DNA could simplify and lower the cost of making synthetic chromosomes, according to its creators at University of Southern California (USC) Dornsife. Known as ‘CReATiNG’ (Cloning Reprogramming and Assembling Tiled Natural Genomic DNA), the method offers a simpler and… Read More

#News

Synthetic DNA molecule
#Drug discovery #In Focus Report #Synthetic biology #Synthetic DNA

In depth eReport on Synthetic Biology: Is it the next big thing?

Synthetic biology has shown significant potential to the drug discovery sector. Although not a new area of science, the prominence of this technology and its applications – evident during the Covid-19 pandemic – have increased of late. This has created advances in the development of new medicines and our… Read More

#Editor's Choice #News

#Drug discovery #In Focus Report #Synthetic biology #Synthetic DNA

Synthetic Biology: Is it the next big thing?

Download this exclusive DDW eReport to learn more about: The global market for synthetic biology: its potential and where innovative drug development is taking place Analysis of regional markets and the key players within the synthetic biology sector How advances in the synthetic biology field are impacting drug discovery – from… Read More

#DDW eBooks #DDW In Focus eReports #Intelligence

Synthetic DNA
#Biotherapeutics #DNA #Synthetic biology #Synthetic DNA

Accelerating biotherapy and personalised medicine with long DNA

Listen to this article on the DDW Podcast: Matt Hill, Founder and CEO of Elegen writes about the importance of innovation in DNA synthesis to address critical bottlenecks in biotherapy development. With advanced technology and a growing understanding of the underlying biology, biotherapy development has evolved. Since 2010, investments in the… Read More

#Exclusive Content